10-Q: Knowles Corporation Reports Mixed Q1 2025 Results; Divestiture Impacts Performance

Knowles Corporation's Q1 2025 results reflect the impact of the CMM divestiture, with a slight revenue decrease and strategic restructuring efforts underway.

Summary

• Knowles Corporation reported a net loss of $2.0 million for Q1 2025, compared to a net profit of $2.5 million in Q1 2024.
• Revenues decreased slightly to $132.2 million from $133.3 million year-over-year.
• The company completed the sale of its Consumer MEMS Microphones (CMM) segment to Syntiant Corp. on December 27, 2024, impacting the comparability of results.
• Restructuring charges of $2.9 million were recorded in Q1 2025 related to headcount reductions following the CMM business sale.
• The company repurchased 300,768 shares of common stock for $5.0 million during the quarter.
• Knowles had $189.0 million remaining under its share repurchase program as of March 31, 2025.

Sentiment

Score: 5

Explanation: The sentiment is neutral. While the company reported a net loss, it is actively restructuring and focusing on higher-margin segments. The mixed results and strategic adjustments balance positive and negative aspects.

Positives

• Gross profit remained relatively stable at $53.3 million in Q1 2025 compared to $53.2 million in Q1 2024.
• Interest expense decreased by $1.7 million due to a lower outstanding revolving credit facility balance and lower imputed interest expense on the Seller Note.
• PD segment EBIT increased by $5.3 million due to lower operating expenses and higher gross profit.
• The company is actively managing costs and implementing pricing actions to mitigate the impact of tariffs.

Negatives

• Net loss of $2.0 million, compared to a net profit of $2.5 million in the same period last year.
• Slight decrease in overall revenues from $133.3 million to $132.2 million.
• MSA segment EBIT decreased by $3.5 million due to lower gross profit and higher operating expenses.
• Other expense increased by $0.9 million, primarily representing unrealized losses in investment balances.
• The effective tax rate from continuing operations was a high 150.0%.

Risks

• Global economic instability, including inflation and geopolitical uncertainties, could impact the company's performance.
• Increasing competition and new entrants in the market pose a threat to the company's market share.
• Escalating international trade tensions and tariffs could adversely affect the company's results.
• Fluctuations in currency exchange rates and commodity prices present financial risks.
• The company's dependence on a limited number of large customers could create vulnerability.
• Cybersecurity incidents could disrupt operations and compromise sensitive information.

Future Outlook

The company is focused on transforming into an industrial technology company, leveraging its Precision Devices and MedTech & Specialty Audio segments. They anticipate that normalizing inventory levels in the industrial markets will benefit the Precision Devices segment. The company is also taking measures to control costs and implement pricing actions to mitigate the impact of tariffs.

Management Comments

• The divestiture supports Knowles' continued transformation into an industrial technology company.
• We have incurred some amount of dis-synergies following the sale of the CMM business due to the reduced size of our company and, as a result, we have undertaken actions to help ensure that our cost structure is appropriate to support our remaining businesses.
• As inventory levels in the industrial markets have recently begun to normalize, our Precision Devices segment has experienced increased distribution orders for the past two quarters.
• With bookings increasing we have seen backlog across our capacitor products increase for the past two quarters.

Industry Context

The company's strategic shift towards industrial technology aligns with the growing demand in the defense, medtech, industrial, and electrification markets. The divestiture of the CMM business reflects a focus on higher-margin, specialized components. The company's performance is also influenced by broader economic factors, such as global trade tensions and supply chain dynamics.

Comparison to Industry Standards

• It is difficult to compare Knowles directly to industry standards without specific competitor data, but the company's focus on high-performance components in medtech, defense, and industrial markets positions it against companies like Murata, TDK, and AVX in specific product categories.
• The adjusted EBIT margin of 16.4% is a key indicator of profitability compared to peers, and the company's ability to maintain or improve this margin will be critical.
• The share repurchase program is a common capital allocation strategy among mature technology companies, and the remaining authorization of $189.0 million provides flexibility for future buybacks.

Legal Proceedings

• The Company is involved in various legal proceedings and claims arising in the ordinary course of its business.
• The Company owns many patents and other intellectual property pertaining to its products, technology, and manufacturing processes and will take steps to protect and defend its patents and other intellectual property, including through the use of legal proceedings in various jurisdictions around the world.

Related Party Transactions

• The Company recognized revenue totaling $4.3 million during the three months ended March 31, 2025 related to transactions with Syntiant.
• Receivables, net include $2.7 million and $1.8 million due from Syntiant at March 31, 2025 and December 31, 2024, respectively, related to these sales transactions and amounts related to the sale of CMM.

Stakeholder Impact

• Shareholders may be concerned about the net loss, but the share repurchase program could provide some support to the stock price.
• Employees may be affected by the restructuring and headcount reductions.
• Customers may experience changes in product offerings and supply chain dynamics due to the CMM divestiture.
• Suppliers may need to adjust to changes in the company's procurement needs.

Next Steps

• The company will continue to optimize operations and leverage existing programs to reduce the impact from tariffs.
• Management will continue to reassess the need to repatriate the earnings of foreign subsidiaries.
• The company will determine the timing and amount of any future share repurchases based on market conditions and other factors.

Key Dates

Keywords

Knowles, financial results, Q1 2025, divestiture, CMM, restructuring, share repurchase, Precision Devices, MedTech & Specialty Audio, Syntiant